Burnett AK - Search Results

1

Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia.

Tonks A, Pearn L, Musson M, Gilkes A, Mills KI, Burnett AK, Darley RL. Tonks A, et al. Among authors: burnett ak. Leukemia. 2007 Dec;21(12):2495-505. doi: 10.1038/sj.leu.2404961. Epub 2007 Sep 27. Leukemia. 2007. PMID: 17898786

2

Aberrant expression of p21RAS but not p120GAP is a common feature of myelodysplasia.

Gallagher A, Padua RA, al-Sabah A, Hoy T, Burnett AK, Darley RL. Gallagher A, et al. Among authors: burnett ak. Leukemia. 1995 Nov;9(11):1833-40. Leukemia. 1995. PMID: 7475271

3

Oncogenic RAS genes impair erythroid differentiation of erythroleukaemia cells.

Zaker F, Darley RL, al Sabah A, Burnett AK. Zaker F, et al. Among authors: burnett ak. Leuk Res. 1997 Jul;21(7):635-40. doi: 10.1016/s0145-2126(97)00022-2. Leuk Res. 1997. PMID: 9301684

4

Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cells.

McGlynn AP, Padua RA, Burnett AK, Darley RL. McGlynn AP, et al. Among authors: burnett ak. Leuk Res. 2000 Jan;24(1):47-54. doi: 10.1016/s0145-2126(99)00159-9. Leuk Res. 2000. PMID: 10634645

5

Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal.

Tonks A, Tonks AJ, Pearn L, Pearce L, Hoy T, Couzens S, Fisher J, Burnett AK, Darley RL. Tonks A, et al. Among authors: burnett ak. Leukemia. 2004 Jul;18(7):1238-45. doi: 10.1038/sj.leu.2403396. Leukemia. 2004. PMID: 15152269

6

The sensitivity of human cells expressing RUNX1-RUNX1T1 to chemotherapeutic agents.

Tonks A, Pearn L, Mills KI, Burnett AK, Darley RL. Tonks A, et al. Among authors: burnett ak. Leukemia. 2006 Oct;20(10):1883-5. doi: 10.1038/sj.leu.2404364. Epub 2006 Aug 17. Leukemia. 2006. PMID: 16932340 No abstract available.

7

CD200 as a prognostic factor in acute myeloid leukaemia.

Tonks A, Hills R, White P, Rosie B, Mills KI, Burnett AK, Darley RL. Tonks A, et al. Among authors: burnett ak. Leukemia. 2007 Mar;21(3):566-8. doi: 10.1038/sj.leu.2404559. Epub 2007 Jan 25. Leukemia. 2007. PMID: 17252007 No abstract available.

8

OGG1 is a novel prognostic indicator in acute myeloid leukaemia.

Liddiard K, Hills R, Burnett AK, Darley RL, Tonks A. Liddiard K, et al. Among authors: burnett ak. Oncogene. 2010 Apr 1;29(13):2005-12. doi: 10.1038/onc.2009.462. Epub 2009 Dec 21. Oncogene. 2010. PMID: 20023702

9

CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia.

Coles SJ, Wang EC, Man S, Hills RK, Burnett AK, Tonks A, Darley RL. Coles SJ, et al. Among authors: burnett ak. Leukemia. 2011 May;25(5):792-9. doi: 10.1038/leu.2011.1. Epub 2011 Jan 28. Leukemia. 2011. PMID: 21274000 Free PMC article.

10

RUNX1-ETO deregulates the proliferation and growth factor responsiveness of human hematopoietic progenitor cells downstream of the myeloid transcription factor, MYCT1.

Liddiard K, Burnett AK, Darley RL, Tonks A. Liddiard K, et al. Among authors: burnett ak. Leukemia. 2012 Jan;26(1):177-9. doi: 10.1038/leu.2011.188. Epub 2011 Jul 29. Leukemia. 2012. PMID: 21799513 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters